Opaleye Management’s Adaptimmune Therapeutics ADAP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2016
Q3
Sell
-40,000
Closed -$326K 45
2016
Q2
$326K Sell
40,000
-135,300
-77% -$1.1M 0.22% 48
2016
Q1
$1.43M Buy
+175,300
New +$1.43M 0.89% 36